Regulation of cutaneous wound healing by GCN2
Regulation of cutaneous wound healing by GCN2
批准号:
10417023
负责人:
DAN F SPANDAU
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-01 至 2023-12-31
关键词:
3-DimensionalAcuteAddressAffectAgingAmericanBiochemicalBiological AssayBiological ModelsBiopsyCRISPR/Cas technologyCaringCell Culture TechniquesCellsCellular StressClinical ResearchClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsCutaneousDataDiabetes MellitusDiagnosisDiseaseDisease ProgressionEIF-2alphaElderlyEnvironmentEpithelialEukaryotic Initiation Factor-2ExonsFailureGenesGeneticGenetic TranslationGoalsGranulation TissueGrowthHealth Care CostsHealthcare SystemsHomeostasisHumanHuman VolunteersImmuneIn VitroIndividualInfectionInflammatoryInitiator tRNAInterventionKRP proteinKnock-outLaboratoriesMalnutritionMedicalMessenger RNAMolecularNutrientObesityOrganPathologicPathway interactionsPatientsPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhasePhosphorylationPhosphotransferasesPlayProtein BiosynthesisProtein InhibitionProtein KinaseProteinsQuality of lifeRegulationResolutionRibosomesRoleSignal PathwaySiteSkinSkin injurySkin wound healingSpecimenStasis UlcerStressSubstance abuse problemSystemTherapeuticTissuesTranslationsUnited StatesVenousVeteransWound healing therapyacute woundbiological adaptation to stressbody systemcell motilitychronic woundcost effectivenessdecubitus ulcerdiabetic ulcerenvironmental stressorepithelial woundflexibilitygenome-wide analysishuman old age (65+)improvedin vivoinhibitorkeratinocytekeratinocyte differentiationmigrationmilitary veterannovel therapeuticspolysome profilingprotein kinase Precruitresponsesealskin woundtooltranscriptome sequencingtwo-dimensionalwoundwound bedwound closurewound healingwound response
中文摘要
每年约有650万美国人被诊断出患有皮肤慢性伤口,造成
美国的医疗体系每年超过200亿美元。通常这些慢性伤口会被发现
在老年患者中,高达85%的慢性伤口患者超过65岁,或
并发疾病,如糖尿病、肥胖症、营养不良或药物滥用。同样,未能
妥善愈合伤口是退伍军人面临的一个主要问题,因为目前有900多万人
65岁以上的退伍军人,约占退伍军人总数的38%。通常,这些患者会受到
一长串的各种治疗方法,往往没有机械的理由,而且它们仍然缺乏充分的
解决他们的伤口。因此,更好地了解慢性创面的具体原因,并更好地
需要一系列治疗选项来解决这一未得到满足的需求。一旦出现任何类型的慢性伤口,
无论是糖尿病溃疡,卧位性溃疡,还是静脉淤积性溃疡,都是
伤口闭合是指表皮细胞不能使伤口床重新上皮化。慢性伤口仍然存在
停滞在炎症阶段,角质形成细胞很少或没有在伤口床上迁移。近期
数据表明,一种进化上保守的机制,称为综合应激反应
(ISR),对人类皮肤正常的再上皮化至关重要。ISR由四个截然不同但又相互关联的
蛋白激酶被各种类型的环境应激激活,导致磷酸化
相同的靶蛋白,真核细胞启动因子2在其α亚基上(eIF2α~P)。其后果是
EIF2α~P包括对蛋白质翻译的全局抑制,从而保存重要的细胞能量储存,以及
选择性翻译与应激反应相关的基因。重要的是,那是最近
证明在正常皮肤中,ISR在角质形成细胞分化过程中被激活。此外,
角质形成细胞缺乏一种eIF 2α~P蛋白激酶(GCN2),它在
表皮分化)形成异常、角化不良、缺乏正常屏障功能的皮肤。如果GCN2
在角质形成细胞中表达被敲除(使用CRISPR/Cas9的第12外显子缺失),角质形成细胞
在不影响单个细胞运动的情况下缺乏上皮片迁移。这些数据导致了
假设GCN2是皮肤创伤反应的关键成分,并且操纵
通过药物进行的ISR将促进伤口愈合。最后一点特别耐人寻味,因为
几种调节ISR的药物(无论是积极的还是消极的)已经在进行人体临床试验
不相关的疾病,可能会加速将任何有希望的药物迅速投入人体试验。
在这项提议中,关于ISR在伤口愈合中的作用的初步研究使用了包括两个模型系统-
角质形成细胞的体外生长以及三维器官皮肤系统和人类临床
活体研究。体外研究将确定损伤后GCN2激活的机制
角质形成细胞培养,确定角质形成细胞迁移中的哪一种功能受到损害
GCN2失活,并分析哪些基因和信号通路被增强蛋白激活
结合多聚体分析和rna-seq分析进行翻译。体内研究将确定
ISR特异性激活剂/抑制剂在皮肤伤口愈合中的作用,确定是否正常失活
老年患者的ISR改变了正常的伤口愈合,并检查了慢性伤口的病理活检
以确定在疾病发展过程中ISR是否失活。慢性病的管理
创伤以及加速解决急性皮肤损伤的可能性对以下方面至关重要
退伍军人,既是退伍军人患者的生活质量问题,也是退伍军人医疗保健的成本效益问题
系统。这项建议的目标是确定特定的治疗或机制途径,以
减轻慢性创伤的后果。
英文摘要
Approximately 6.5 million Americans are diagnosed with a cutaneous chronic wound each year, costing the
healthcare system in the United States over 20 billion dollars annually. Often these chronic wounds are found
in geriatric individuals, up to 85% of patients with chronic wounds are over 65 years old, or in patients with
concurrent diseases such as diabetes, obesity, malnutrition, or substance abuse. Similarly, the failure to
properly heal wounds is a major problem for the Veteran population as presently there are over 9 million
Veterans over the age of 65, or about 38% of the total Veteran population. Often these patients are subjected
to a litany of various treatments, frequently without mechanistic justification, and they still lack adequate
resolution of their wounds. Therefore, a better understanding of specific causes of chronic wounds and a better
menu of treatment options is needed to address this unmet need. Once any type of chronic wound appears,
whether it is a diabetic ulcer, decubitus ulcer, or venous stasis ulcer, one of the primary limiting factors in
wound closure is the inability of epidermal cells to re-epithelialize the wound bed. Chronic wounds remain
arrested in the inflammatory phase with little to no migration of keratinocytes across the wound bed. Recent
data have demonstrated that an evolutionarily-conserved mechanism, called the Integrated Stress Response
(ISR), is crucial for normal re-epithelialization in human skin. The ISR consists of four distinct but related
protein kinases are activated by various types of environmental stress leading to the phosphorylation of the
same target protein, eukaryotic initiation factor 2 on its alpha subunit (eIF2α~P). The consequences of
eIF2α~P include a global inhibition of protein translation, which conserves vital cellular energy stores, and the
selective translation of genes associated with responding to the stress. Importantly, it was recently
demonstrated that the ISR is activated in differentiating keratinocytes in normal skin. Furthermore,
keratinocytes deficient for one of the eIF2α~P protein kinases (GCN2, which phosphorylates eIF2α~P during
epidermal differentiation) form abnormal, dyskeratotic skin lacking a normal barrier function. If GCN2
expression is knocked-out in human keratinocytes (an exon 12 deletion using CRISPR/CAS9), keratinocytes
are deficient in epithelial sheet migration without affecting individual cell motility. These data led to the
hypothesis that GCN2 is a critical component of the cutaneous wounding response, and that manipulation of
the ISR via pharmaceutical agents will improve wound healing. This last point is particularly intriguing, because
several drugs that regulate the ISR (either positively or negatively) are already in human clinical trials for
unrelated diseases which could accelerate bringing any drugs that showed promise rapidly into human trials.
The initial studies into the role of the ISR on wound healing in this proposal use model systems including two-
dimensional keratinocyte growth in vitro as well as three-dimensional organ skin systems and human clinical
studies in vivo. In vitro studies will define the mechanism of GCN2 activation following wounding of the
keratinocyte cell culture, determine which function in keratinocyte sheet migration is compromised following
GCN2 inactivation, and analyze which genes and signaling pathways are activated by enhanced protein
translation using a combination of polysome profiling and RNA-seq analyses. In vivo studies will determine the
utility of ISR-specific activators/inhibitors on cutaneous wound healing, determine if the inactivation of normal
ISR in geriatric patients alters normal wound healing, and examine pathological biopsies from chronic wounds
to determine is the ISR is inactivated during the progression of this disease. The management of chronic
wounds, as well as the potential to accelerate resolution of acute cutaneous injuries, is of critical importance to
Veterans, both as quality of life issues for Veteran patients and cost-effectiveness of medical care for the VA
system. It is the objective of this proposal to identify specific therapeutic or mechanistic pathways that can
alleviate the consequences of chronic wounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of cutaneous wound healing by GCN2
-
批准号:10651695
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAN F SPANDAU
-
依托单位:
Regulation of cutaneous wound healing by GCN2
-
批准号:9891914
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:DAN F SPANDAU
-
依托单位:
Wounding therapy and photocarcinogenesis
-
批准号:8783059
-
项目类别:
-
资助金额:$31.98万
-
财政年份:2014
-
负责人:DAN F SPANDAU
-
依托单位:
Wounding therapy and photocarcinogenesis
-
批准号:9185418
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2014
-
负责人:DAN F SPANDAU
-
依托单位:
Wounding Therapy and Photocarcinogenesis
-
批准号:10704206
-
项目类别:
-
资助金额:$45.07万
-
财政年份:2014
-
负责人:DAN F SPANDAU
-
依托单位:
Mechanisms of photocarcinogenesis in geriatric skin
-
批准号:8532899
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2012
-
负责人:DAN F SPANDAU
-
依托单位:
Mechanisms of photocarcinogenesis in geriatric skin
-
批准号:8371726
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2012
-
负责人:DAN F SPANDAU
-
依托单位:
Mechanisms of photocarcinogenesis in geriatric skin
-
批准号:9064190
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2012
-
负责人:DAN F SPANDAU
-
依托单位:
Role of senescent fibroblasts in UVB-induced carcinogenesis
-
批准号:7753681
-
项目类别:
-
资助金额:$16.75万
-
财政年份:2009
-
负责人:DAN F SPANDAU
-
依托单位:
Role of senescent fibroblasts in UVB-induced carcinogenesis
-
批准号:7589456
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2009
-
负责人:DAN F SPANDAU
-
依托单位:
Ultraviolet B irradiation of human keratinocytes
-
批准号:6611406
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2001
-
负责人:DAN F SPANDAU
-
依托单位:
Ultraviolet B irradiation of human keratinocytes
-
批准号:6361876
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2001
-
负责人:DAN F SPANDAU
-
依托单位:
Ultraviolet B irradiation of human keratinocytes
-
批准号:6518235
-
项目类别:
-
资助金额:$28.68万
-
财政年份:2001
-
负责人:DAN F SPANDAU
-
依托单位:
Ultraviolet B irradiation of human keratinocytes
-
批准号:6763196
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2001
-
负责人:DAN F SPANDAU
-
依托单位:
海外基金